BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gatto M, Alvaro D. New insights on cholangiocarcinoma. World J Gastrointest Oncol 2010; 2(3): 136-145 [PMID: 21160821 DOI: 10.4251/wjgo.v2.i3.136]
URL: https://www.wjgnet.com/1948-5204/full/v2/i3/136.htm
Number Citing Articles
1
Vincenzo Cardinale, Maria Consiglia Bragazzi, Guido Carpino, Alessia Torrice, Yunfang Wang, Lola McAdams Reid, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinomas: New Insights from the Discovery of Stem Cell Niches in Peribiliary Glands of the Biliary TreeAdvances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/794953
2
J. Munding, A. Tannapfel. Anatomisch-pathologische Besonderheiten der Klatskin-TumorenDer Chirurg 2012; 83(3): 208 doi: 10.1007/s00104-011-2175-8
3
Ahmed Abdel-Razik, Youssif ElMahdy, Ehab El hanafy, Rania Elhelaly, Rasha Elzehery, Ahmed M. Tawfik, Waleed Eldars. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary ObstructionsThe American Journal of the Medical Sciences 2016; 351(3): 259 doi: 10.1016/j.amjms.2015.12.013
4
F. Bernuzzi, F. Marabita, A. Lleo, M. Carbone, M. Mirolo, M. Marzioni, G. Alpini, D. Alvaro, K. M. Boberg, M. Locati, G. Torzilli, L. Rimassa, F. Piscaglia, X.-S. He, C. L. Bowlus, G.-X. Yang, M. E. Gershwin, P. Invernizzi. Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinomaClinical & Experimental Immunology 2016; 185(1): 61 doi: 10.1111/cei.12776
5
Amy L. Collins, Sylwia Wojcik, James Liu, Wendy L. Frankel, Hansjuerg Alder, Lianbo Yu, Thomas D. Schmittgen, Carlo M. Croce, Mark Bloomston. A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic AdenocarcinomaAnnals of Surgical Oncology 2014; 21(1): 133 doi: 10.1245/s10434-013-3240-y
6
Alexander Arnold, Marcus Bahra, Dido Lenze, Maren Bradtmöller, Katrin Guse, Claire Gehlhaar, Hendrik Bläker, Frank L. Heppner, Arend Koch. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assayExperimental and Molecular Pathology 2015; 99(2): 344 doi: 10.1016/j.yexmp.2015.08.003
7
Francesco M. Serafini, David Radvinsky. The pathways of genetic transformation in cholangiocarcinogenesisCancer Genetics 2016; 209(12): 554 doi: 10.1016/j.cancergen.2016.07.004
8
F. Rassam, E. Roos, K. P. van Lienden, J. E. van Hooft, H. J. Klümpen, G. van Tienhoven, R. J. Bennink, M. R. Engelbrecht, A. Schoorlemmer, U. H. W. Beuers, J. Verheij, M. G. Besselink, O. R. Busch, T. M. van Gulik. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experienceLangenbeck's Archives of Surgery 2018; 403(3): 289 doi: 10.1007/s00423-018-1649-2
9
Aman Tedasen, Araya Khoka, Siribhorn Madla, Somchai Sriwiriyajan, Potchanapond Graidist. Anticancer effects of piperine-free Piper nigrum extract on cholangiocarcinoma cell linesPharmacognosy Magazine 2020; 16(68): 28 doi: 10.4103/pm.pm_288_19
10
Kumar Sandrasegaran, Christine O. Menias. Imaging and Screening of Cancer of the Gallbladder and Bile DuctsRadiologic Clinics of North America 2017; 55(6): 1211 doi: 10.1016/j.rcl.2017.06.005
11
ALENA MÜLLER, SAMARPITA BARAT, XI CHEN, KHAC CUONG BUI, PRZEMYSLAW BOZKO, NISAR P. MALEK, RUBEN R. PLENTZ. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell linesInternational Journal of Oncology 2016; 48(5): 2025 doi: 10.3892/ijo.2016.3411
12
Detian Yuan, Shan Huang, Emanuel Berger, Lei Liu, Nina Gross, Florian Heinzmann, Marc Ringelhan, Tracy O. Connor, Mira Stadler, Michael Meister, Julia Weber, Rupert Öllinger, Nicole Simonavicius, Florian Reisinger, Daniel Hartmann, Rüdiger Meyer, Maria Reich, Marco Seehawer, Valentina Leone, Bastian Höchst, Dirk Wohlleber, Simone Jörs, Marco Prinz, Duncan Spalding, Ulrike Protzer, Tom Luedde, Luigi Terracciano, Matthias Matter, Thomas Longerich, Percy Knolle, Thomas Ried, Verena Keitel, Fabian Geisler, Kristian Unger, Einat Cinnamon, Eli Pikarsky, Norbert Hüser, Roger J. Davis, Darjus F. Tschaharganeh, Roland Rad, Achim Weber, Lars Zender, Dirk Haller, Mathias Heikenwalder. Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROSCancer Cell 2017; 31(6): 771 doi: 10.1016/j.ccell.2017.05.006
13
Adrian P. Mansini, Estanislao Peixoto, Kristen M. Thelen, Cesar Gaspari, Sujeong Jin, Sergio A. Gradilone. The cholangiocyte primary cilium in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1245 doi: 10.1016/j.bbadis.2017.06.006
14
Carlos L. Antunes, Carlos L. Antunes, Tony Richard O. Almeida, Nélia Raposeiro, Belarmino Gonçalves, Paulo Almeida. Using a tubular electrode for radiofrequency ablationCOMPEL - The international journal for computation and mathematics in electrical and electronic engineering 2012; 31(4): 1077 doi: 10.1108/03321641211227320
15
Sirintip Boonjaraspinyo, Zhiliang Wu, Thidarut Boonmars, Sasithorn Kaewkes, Watchalin Loilome, Paiboon Sithithaworn, Isao Nagano, Yuzo Takahashi, Puangrat Yongvanit, Vajarabhongsa Bhudhisawasdi. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinomaParasitology International 2012; 61(1): 145 doi: 10.1016/j.parint.2011.07.008
16
Sascha A. Müller, Arianeb Mehrabi, Nuh N. Rahbari, Rene Warschkow, Heike Elbers, Christine Leowardi, Hamidreza Fonouni, Ignazio Tarantino, Peter Schemmer, Bruno M. Schmied, Markus W. Büchler. Allogeneic Blood Transfusion Does Not Affect Outcome After Curative Resection for Advanced CholangiocarcinomaAnnals of Surgical Oncology 2014; 21(1): 155 doi: 10.1245/s10434-013-3226-9
17
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_29-1
18
Tae Min You, Kee-Deog Kim, Ho-Gul Jeong, Wonse Park. Mandibular metastasis of cholangiocarcinoma: A case reportImaging Science in Dentistry 2015; 45(4): 247 doi: 10.5624/isd.2015.45.4.247
19
ELISA PAOLICCHI, PAOLA PACETTI, ELISA GIOVANNETTI, ANDREA MAMBRINI, MASSIMO ORLANDI, FRANCESCO CREA, ANTONELLO A. ROMANI, ROBERTA TARTARINI, ROMANO DANESI, GODEFRIDUS J. PETERS, MAURIZIO CANTORE. A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinomaOncology Letters 2013; 6(5): 1487 doi: 10.3892/ol.2013.1559
20
Larisa E Vasilieva, Stefanos I Papadhimitriou, Spyros P Dourakis. Modern diagnostic approaches to cholangiocarcinomaHepatobiliary & Pancreatic Diseases International 2012; 11(4): 349 doi: 10.1016/S1499-3872(12)60192-1
21
Samarpita Barat, Przemyslaw Bozko, Xi Chen, Tim Scholta, Franziska Hanert, Julian Götze, Nisar P. Malek, Ludwig Wilkens, Ruben R. Plentz. Targeting c-MET by LY2801653 for treatment of cholangiocarcinomaMolecular Carcinogenesis 2016; 55(12): 2037 doi: 10.1002/mc.22449
22
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 549 doi: 10.1007/978-3-319-26956-6_29
23
Paiboon Sithithaworn, Puangrat Yongvanit, Kunyarat Duenngai, Nadda Kiatsopit, Chawalit Pairojkul. Roles of liver fluke infection as risk factor for cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences 2014; 21(5): 301 doi: 10.1002/jhbp.62
24
Pankaj Prasoon, Kohei Miura, Kizuki Yuza, Yuki Hirose, Jun Sakata, Toshifumi Wakai. Bile Duct Cancer2019;  doi: 10.5772/intechopen.82113
25
Patricia Marti, Claudia Stein, Tanja Blumer, Yann Abraham, Michael T. Dill, Monika Pikiolek, Vanessa Orsini, Giorgia Jurisic, Philippe Megel, Zuzanna Makowska, Claudia Agarinis, Luigi Tornillo, Tewis Bouwmeester, Heinz Ruffner, Andreas Bauer, Christian N. Parker, Tobias Schmelzle, Luigi M. Terracciano, Markus H. Heim, Jan S. Tchorz. YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factorsHepatology 2015; 62(5): 1497 doi: 10.1002/hep.27992
26
Bendong Chen, Wenyan Zhou, Wenchao Zhao, Peng Yuan, Chaofeng Tang, Genwang Wang, Junzhi Leng, Jinlong Ma, Xiaowen Wang, Yongfeng Hui, Qi Wang. Oxaliplatin reverses the GLP‑1R‑mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signalingOncology Letters 2019;  doi: 10.3892/ol.2019.10497
27
Sarah JL Payne, Justin Stebbing, Peter Wilson, Sarah Slater. Outcomes in unresectable and locally advanced resected cholangiocarcinomaExpert Review of Anticancer Therapy 2011; 11(5): 705 doi: 10.1586/era.11.32
28
Zi-Ying Lin, Zhen-Xing Liang, Pei-Lin Zhuang, Jie-Wei Chen, Yun Cao, Li-Xu Yan, Jing-Ping Yun, Dan Xie, Mu-Yan Cai. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levelsBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2827-7
29
Benjamin R. Kipp, Jesse S. Voss, Sarah E. Kerr, Emily G. Barr Fritcher, Rondell P. Graham, Lizhi Zhang, W. Edward Highsmith, Jun Zhang, Lewis R. Roberts, Gregory J. Gores, Kevin C. Halling. Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinomaHuman Pathology 2012; 43(10): 1552 doi: 10.1016/j.humpath.2011.12.007
30
Bishwanath Acharya, Wanna Chaijaroenkul, Kesara Na-Bangchang. Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathwaysJournal of Pharmacy and Pharmacology 2021; 73(9): 1191 doi: 10.1093/jpp/rgab036
31
Arvind Srinath, Benjamin L. Shneider. Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney DiseaseJournal of Pediatric Gastroenterology & Nutrition 2012; 54(5): 580 doi: 10.1097/MPG.0b013e31824711b7
32
Robbins Basic Pathology2013; : 603 doi: 10.1016/B978-1-4377-1781-5.00015-5
33
Carlos L. Antunes, Carlos L. Antunes, Tony Richard O. Almeida, Nélia Raposeiro. Saline‐enhanced RF ablation on a cholangiocarcinoma: a numerical simulationCOMPEL - The international journal for computation and mathematics in electrical and electronic engineering 2012; 31(4): 1055 doi: 10.1108/03321641211227302
34
Fany K. Segura-López, Francisco Avilés-Jiménez, Alfredo Güitrón-Cantú, Hilda A. Valdéz-Salazar, Samuel León-Carballo, Leoncio Guerrero-Pérez, James G. Fox, Javier Torres. Infection withHelicobacter bilisbut notHelicobacter hepaticuswas Associated with Extrahepatic CholangiocarcinomaHelicobacter 2015; 20(3): 223 doi: 10.1111/hel.12195
35
Thomas von Hahn, Sandra Ciesek, Gerd Wegener, Ruben R. Plentz, Tobias J. Weismüller, Heiner Wedemeyer, Michael P. Manns, Tim F. Greten, Nisar P. Malek. Epidemiological trends in incidence and mortality of hepatobiliary cancers in GermanyScandinavian Journal of Gastroenterology 2011; 46(9): 1092 doi: 10.3109/00365521.2011.589472
36
Jamie E. Anderson, Alan W. Hemming, David C. Chang, Mark A. Talamini, Kristin L. Mekeel. Surgical Management Trends for Cholangiocarcinoma in the USA 1998–2009Journal of Gastrointestinal Surgery 2012; 16(12): 2225 doi: 10.1007/s11605-012-1980-9
37
Mona El Khatib, Anna Kalnytska, Vindhya Palagani, Uta Kossatz, Michael P. Manns, Nisar P. Malek, Ludwig Wilkens, Ruben R. Plentz. Inhibition of hedgehog signaling attenuates carcinogenesisin vitroand increases necrosis of cholangiocellular carcinomaHepatology 2013; 57(3): 1035 doi: 10.1002/hep.26147
38
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 99 doi: 10.1007/978-3-642-40558-7_7
39
Surachate Siripongsakun, Sirachat Vidhyarkorn, Sirivipa Charuswattanakul, Poemlarp Mekraksakit, Prakongboon Sungkasubun, Nuphat Yodkhunnathum, Sutthirak Tangruangkiat, Napat Ritlumlert, Thaniya Sricharunrat, Sirima Jaroenpatarapesaj, Kamonwan Soonklang, Anond Kulthanmanusorn, Chirayu U Auewarakul, Chulabhorn Mahidol. Ultrasound surveillance for cholangiocarcinoma in an endemic area: A prove of survival benefitsJournal of Gastroenterology and Hepatology 2018; 33(7): 1383 doi: 10.1111/jgh.14074
40
Bo Tang, Jian Du, Yang Li, Fang Tang, Zhenran Wang, Songqing He. EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0271-6
41
Kanawut Kotawong, Wanna Chaijaroenkul, Phunuch Muhamad, Kesara Na-Bangchang. Cytotoxic activities and effects of atractylodin and β-eudesmol on the cell cycle arrest and apoptosis on cholangiocarcinoma cell lineJournal of Pharmacological Sciences 2018; 136(2): 51 doi: 10.1016/j.jphs.2017.09.033
42
Rocio I. R. Macias. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological PerspectivesISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/828074